Table 2. Recommended Dosages of FLOVENT Inhalation Aerosol Previous Therapy Recommended Starting Dosage Highest Recommended Dosage Bronchodilators alone 88 mcg twice daily 440 mcg twice daily Inhaled corticosteroids 88-220 mcg twice daily * 440 mcg twice daily Oral corticosteroids * 880 mcg twice daily 880 mcg twice daily * Starting dosages above 88 mcg twice daily may be considered for patients with poorer asthma control or those who have previously required doses of inhaled corticosteroids that are in the higher range for that specific agent. NOTE: In all patients, it is desirable to titrate to the lowest effective dosage once asthma stability is achieved. * For Patients Currently Receiving Chronic Oral Corticosteroid Therapy: Prednisone should be reduced no faster than 2.5 mg/ day on a weekly basis, beginning after at least 1 week of therapy with FLOVENT Inhalation Aerosol. Patients should be carefully monitored for signs of asthma instability, including serial objective measures of airflow, and for signs of adrenal insufficiency (see WARNINGS). Once prednisone reduction is complete, the dosage of fluticasone propionate should be reduced to the lowest effective dosage. Geriatric Use: In studies where geriatric patients (65 years of age or older, see PRECAUTIONS) have been treated with FLOVENT Inhalation Aerosol, efficacy and safety did not differ from that in younger patients. Consequently, no dosage adjustment is recommended. Directions for Use Illustrated Patient's Instructions for Use accompany each package of FLOVENT Inhalation Aerosol. HOW SUPPLIED FLOVENT 44 mcg Inhalation Aerosol is supplied in 7.9-g canisters containing 60 metered inhalations in institutional pack boxes of 1 (NDC 0173-0497-00) and in 13-g canisters containing 120 metered inhalations in boxes of 1 (NDC 0173-0491-00). | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
